These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1321957)

  • 21. Onset dynamics of reentrant tachycardia and rate-dependent conduction changes in canine ventricular muscle: effects of Na+ and Ca2+ channel blockade.
    Lemarbre F; Vinet A; Vermeulen M; Cardinal R
    J Electrocardiol; 2000 Oct; 33(4):349-60. PubMed ID: 11099360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiological properties of SD-3211, a novel putative Ca2+ antagonist, in isolated guinea pig and rabbit hearts.
    Miyawaki N; Furuta T; Shigei T; Yamauchi H; Iso T
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):769-75. PubMed ID: 1703599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of human induced pluripotent stem cell-derived cardiomyocytes sheets with microelectrode array system to estimate antiarrhythmic properties of multi-ion channel blockers.
    Izumi-Nakaseko H; Hagiwara-Nagasawa M; Naito AT; Goto A; Chiba K; Sekino Y; Kanda Y; Sugiyama A
    J Pharmacol Sci; 2018 Aug; 137(4):372-378. PubMed ID: 30126708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of semotiadil fumarate (SD-3211) and its enantiomer, SD-3212, on the changes in cytosolic Ca2+ and tension caused by KCl and norepinephrine in isolated rat aortas.
    Murakami K; Shindo K; Ito KM; Ito K
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):262-7. PubMed ID: 7752651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Block of T-type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonists.
    Cohen CJ; Spires S; Van Skiver D
    J Gen Physiol; 1992 Oct; 100(4):703-28. PubMed ID: 1281221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic and cardiohemodynamic effects of a novel Ca(2+) channel blocker, AH-1058, assessed in canine arrhythmia models.
    Takahara A; Sugiyama A; Dohmoto H; Yoshimoto R; Hashimoto K
    Eur J Pharmacol; 2000 Jun; 398(1):107-12. PubMed ID: 10856454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil).
    Barron E; Marshall RJ; Martorana M; Winslow E
    Br J Pharmacol; 1986 Nov; 89(3):603-12. PubMed ID: 3492234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Slow antegrade excitation and delayed retrograde activation through an "inexcitable zone": A basis for arrhythmia formation in infarcted myocardium ex vivo.
    Patterson E; Scherlag BJ
    J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1213-1222. PubMed ID: 28570022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
    Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bepridil versus nifedipine for ventricular tachycardia induced in the late postinfarction phase in conscious dogs.
    Brachmann J; Aidonidis I; Dembowsky K; Seller H; Kuebler W
    Cardiology; 1989; 76(3):211-21. PubMed ID: 2789099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A possible involvement of sodium channel blockade of class-I-type antiarrhythmic agents in postischemic contractile recovery of isolated, perfused hearts.
    Takeo S; Tanonaka K; Hayashi M; Yamamoto K; Liu JX; Kamiyama T; Yamaguchi N; Miura A; Natsukawa T
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1403-9. PubMed ID: 7791114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electromechanical effects of bepridil on rabbit isolated hearts.
    Anno T; Furuta T; Itoh M; Kodama I; Toyama J; Yamada K
    Br J Pharmacol; 1984 Jan; 81(1):41-7. PubMed ID: 6608388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salutary antiarrhythmic effect of combining a K channel blocker and a beta-blocker in a canine model of 7-day-old myocardial infarction.
    Takatsuki S; Mitamura H; Kanki H; Sueyoshi K; Ogawa S
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):914-8. PubMed ID: 10836726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative electrophysiologic effects of bepridil, verapamil and diltiazem in conscious and anesthetized dogs.
    Kantelip JP; Alatienne M; Talmant JM; Ghyselinck N; Duchêne-Marullaz P
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):5-18. PubMed ID: 3493741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of bepridil versus E-4031 on transmural ventricular repolarization and inducibility of ventricular tachyarrhythmias in the dog.
    Izumi D; Chinushi M; Iijima K; Ahara S; Komura S; Furushima H; Hosaka Y; Sanada A; Yagihara N; Aizawa Y
    Pacing Clin Electrophysiol; 2010 Aug; 33(8):950-9. PubMed ID: 20487341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cardiac electrophysiological effects of sparteine and its analogue BRB-I-28 in the rat.
    Pugsley MK; Saint DA; Hayes E; Berlin KD; Walker MJ
    Eur J Pharmacol; 1995 Dec; 294(1):319-27. PubMed ID: 8788447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bepridil, an antiarrhythmic drug, opens mitochondrial KATP channels, blocks sarcolemmal KATP channels, and confers cardioprotection.
    Sato T; Costa AD; Saito T; Ogura T; Ishida H; Garlid KD; Nakaya H
    J Pharmacol Exp Ther; 2006 Jan; 316(1):182-8. PubMed ID: 16174795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog.
    Keren G; Tepper D; Butler B; Torres V; Somberg JC
    Am Heart J; 1984 Nov; 108(5):1236-43. PubMed ID: 6333809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic effects of flecainide against canine ventricular arrhythmias induced by two-stage coronary ligation and halothane-epinephrine.
    Dobmeyer D; Muir WW; Schaal SF
    J Cardiovasc Pharmacol; 1985; 7(2):238-44. PubMed ID: 2581074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective effects of tocainide in canine acute myocardial infarction.
    Hiromasa S; Li ZY; Coto H; Maldonado C; Kupersmith J
    Int J Cardiol; 1990 Apr; 27(1):79-86. PubMed ID: 2110552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.